Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(28 sites)
United States
UCHealth Poudre Valley Hospital, Fort Collins, Colorado UCHealth Harmony, Fort Collins, Colorado UCHealth Greeley Hospital, Greeley, Colorado Longs Peak Hospital, Longmont, Colorado UCHealth Longs Peak Medical Center, Longmont, Colorado UCHealth - Medical Center of the Rockies, Loveland, Colorado Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center, Coral Gables, Florida University of Miami Hospital and Clinics Deerfield Beach, Deerfield Beach, Florida Sylvester Comprehensive Cancer Center, Miami, Florida University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami, Florida University of Miami Hospital and Clinics, Miami, Florida University of Michigan, Ann Arbor, Michigan Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit, Michigan St. David's South Austin Medical Center, Austin, Texas Australia
Epworth Freemasons, Melbourne, Victoria Epworth Hospital, Richmond, Victoria Slade Pharmacy, Richmond, Victoria Canada
Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta Cross Cancer Institute, Edmonton, Alberta McGill University Health Centre, Montreal, Quebec China
Peking University Third Hospital, Beijing, Beijing Municipality Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Shandong Provincial Hospital, Jinan, Shandong The first Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Japan
Japanese Red Cross Medical Center, Shibuya-ku, Tokyo University Hospital,Kyoto Prefectural University of Medicine, Kyoto Taiwan
National Taiwan University Hospital, Taipei Taipei Veterans General Hospital, Taipei